Genetics.The mission of Veritas Int. is to fulfill the promise of the human genome, empowering people to maximize quality and length of life
Veritas Intercontinental has raised €5.0M across 1 funding round from 2 investors, most recently a Series B round in Oct 2020. Based in Madrid, Spain; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-16 | Series B |
| €5.0M |
| Amadeus Capital Partners,Charme Capital Partners |
| View deal → |
